Sapropterin dihydrochloride oral suspension (APR Applied Pharma Research)
盐酸沙丙蝶呤口服混悬液 (APR Applied Pharma Research)
Report date: 2026/04/07 20:00:20
Base Information
Drug NameSapropterin dihydrochloride oral suspension (APR Applied Pharma Research)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMeta Healthcare Ltd
China Registration ClassN/A
Develop Information
Active CompaniesApr Applied Pharma Research SaRelief Therapeutics Holding Sa
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A